In several cancers with bad prognosis, STIL expression has been found up-regulation, including lung cancer (Goto et al., 2013), prostate adenocarcinoma (Wu et al., 2019), bladder cancer (Du et al., 2018), and ovarian cancers (Rabinowicz et al., 2017a). The gene discussed is STIL; the disease is urinary bladder carcinoma.